Prices of a prestigious Chinese alcohol brand are falling, stoking worries about economic growth.
Regulators hit Citigroup, JPMorgan Chase, Goldman Sachs and Bank of America over living will plans
The living wills are a key Federal Reserve and FDIC exercise mandated in the aftermath of the 2008 global financial crisis.
The stock market is in its longest stretch without a 2% sell-off since the financial crisis
Wall Street’s rise to record highs has come with very little volatility.
Stocks making the biggest moves midday: Sarepta Therapeutics, Hertz Global, Asana and more
These are the stocks posting the largest moves in midday trading.
Nearly $109 million in deposits held for fintech Yotta’s customers vanished in Synapse collapse, bank says
Despite mounting pressure to unfreeze all locked bank accounts in the Synapse collapse, messy records have created uncertainty over when that will happen.
Stocks making the biggest moves premarket: Gilead Sciences, Sarepta Therapeutics, Nike and more
These are the stocks posting the largest moves in premarket trading.
Ferrari to unveil new ‘e-building’: Here’s what to know
CNBC’s Robert Frank joins ‘Squawk Box’ to discuss the latest news from Ferrari.
China has spent at least $230 billion to build its EV industry, new study finds
China spent $230.8 billion over more than a decade to develop its electric car industry, according to the Center for Strategic and International Studies.
China talks up support for IPOs. Investors are watching the speed of approval
Chinese authorities this week announced new policy for supporting venture capital, raising hopes for faster approvals of initial public offerings.
How investors can stay protected with emerging market opportunities
BNY’s global head of ETFs warns that investors should account for changing currency levels when investing internationally.